Employer Navigation

CARSGEN Graduate Jobs & Internships

科济生物医药(上海)有限公司成立于2014年10月,是中国首家专注于CAR-T细胞免疫治疗的创新型企业,也是全球知名的实体肿瘤CAR-T细胞治疗研发企业。秉承“科学创造,济世救人”的价值观,科济生物建立了高效的管理、研发、生产团队。公司现有员工150多人,硕士及博士学历员工占50%左右,拥有多名来自全球顶尖生物医药公司的高管及研发人员。

 

CARSGEN currently has 0 opportunities.
Select the following options:

Past CARSGEN Graduate Hiring Statistics

If you’re interested in working at CARSGEN, understanding when they have opened up applications for their graduate programs, graduate jobs and internships is helpful knowledge to have so you know when you might need to apply. Use the below information to see when CARSGEN hires graduates, but more importantly what graduate degree’s and other student attributes they target for their jobs.


Months

Apr 20May 20Jun 20Jul 20Aug 20Sep 20Oct 20Nov 20Dec 20Jan 21Feb 21Mar 21024680 job0 job8 jobs0 job0 job0 job6 jobs0 job0 job0 job0 job0 job
  • count

Job types

  • Graduate Jobs (79%),

  • Internships (21%),

Disciplines

  • Engineering (14%),

  • Pharmacy and Pharmacology (50%),

Locations

  • Shanghai (100%),

Work rights

    Past CARSGEN Graduate Jobs & Internships

    Check out some of CARSGEN's past jobs they have posted on GradConnection over the last 12 months. Understanding the details about what a graduate employer is looking for well before applications have opened can sometimes be the edge you need to secure your first graduate program.


    CARSGEN

    Closed 4 months ago

    协助完成重组蛋白的纯化工艺开发、优化、验证、放大等工作. 协助完成各种蛋白和抗体的纯化及相关活性检测工作

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 4 months ago

    通用型CAR-T相关的项目研发,包括文献分析、方案设计、实施、数据分析及报告撰写

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 4 months ago

    协助起草和修订ELISA,QPCR,HPLC,FACS,无菌检查及支原体检查等的一种或多种方法的质量标准和检定规程;协助在GMP环境下协助执行细胞治疗产品(CART)生产中控、放行及稳定性的日常检测工作,出具检验报告

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 4 months ago

    To support line manager to prepare medical document package including protocol synopsis, briefing book, investigator’s brochure, protocol, ICF, patient dairy, study report, safety summary, efficacy summary etc.; for regulatory submission and ethical committee submission.

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 4 months ago

    协助完成年度培训计划,包括但不限于培训信息整理、培训资料整理、培训现场布置、培训记录跟进及维护

    JOB TYPE

    Internships

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 4 months ago

    主要负责公司细胞生物学相关实验工作,如细胞培养、病毒转染、细胞相关的实验及体内样本的检测等

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Internships

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级。

    JOB TYPE

    Graduate Jobs

    LOCATION

    Shanghai (China)

    CARSGEN

    Closed 8 months ago

    科济生物开展了针对GPC3、EGFR/EGFR VIII 、Claudin18.2等靶点的全球首创及领先的实体瘤CAR-T临床试验,多个项目获得了新药创制国家十三五重大专项支持。科济生物于2017年6月在美国临床肿瘤协会年会(ASCO2017)公布了全球首个肝癌CAR-T临床一期数据:在接受治疗的13名肝癌患者中,无任何患者出现严重毒性(3级或4级)。

    JOB TYPE

    Internships

    LOCATION

    Shanghai (China)

    Search

    Enter an employer or university you want to find in our search bar.